SOM Biotech announces that it has obtained an INNOVATIVE SME seal from the Ministry of Science and Innovation.
This distinction recognizes SOM Biotech’s contribution to R&D innovation. The accreditation highlights the innovative business model, based on a pioneering computational chemistry technology that the company has developed to accelerate and streamline the drug discovery and development process.
Maria Zimina, Business Development Manager, underlines: “Innovation is at the core of SOM Biotech´s business model. We work with a proprietary technology based on artificial intelligence to identify drug candidates with high levels of safety and efficacy. This has allowed us to build a very robust portfolio of drug candidates for diseases where there is a great medical need. Our technology is validated through the positive results we have obtained in different clinical trials. We have also proved that drug development times can be shortened and R&D costs can be drastically lowered, benefiting patients with severe medical conditions.”
Read the post in Spanish here.
